secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUNIC, INC. (IMUX)
CIK:        0001280776
Form:       8-K
Filed at:   2021-10-15T23:59:59+00:00
Accession:  0001193805-21-001455
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunic appoints Patrick Walsh as Chief Business Officer; $380K salary, 120K options
--------------------------------------------------------------------------------

- Patrick Walsh appointed Chief Business Officer, effective Oct 14, 2021.
- Base salary $380,000, signing bonus $60,000, options for 120,000 shares.
- Options vest 25% on first anniversary, then monthly over 36 months; target bonus min 35%.
- Severance: 12 months' base salary on termination without cause; 33% equity vesting (100% near change of control).
- Previously VP Business Development at Akebia Therapeutics; earlier roles at AVEO, Capgemini, Leerink.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1280776/000119380521001455/0001193805-21-001455-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1280776/000119380521001455/e621010_8k-immunic.htm
  HTML page:      https://secwatch.observer/filing/0001193805-21-001455

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer